Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Xinhai Fengyuan Biopharma Technology Development is a prominent pharmaceutical distribution and logistics company based in Beijing, China. Founded in 1998, the company specializes in the supply chain management and distribution of high-value medical consumables and pharmaceutical products, with a strong focus on cardiology, orthopedics, and neurology. In 2014, it was fully acquired by Shanghai Pharmaceuticals Holding Co., Ltd. (SPH), one of China's largest pharmaceutical groups, to serve as a strategic regional hub for its distribution network in Northern China. The company continues to operate as a key subsidiary of SPH, providing integrated healthcare services and logistics solutions to hospitals and medical institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fengyuan Biopharma Technology Development.